title: Continuous renal replacement therapy in critically ill patients.
abstract: We describe our experience with continuous renal replacement therapy (CRRT) in critically ill neonates. From June 1995 to June 1997 36 critically ill oliguric or anuric infants and children underwent continuous arterio-venous (N = 17) or veno-venous (N = 15) renal support. In addition, four neonates were treated with continuous ultrafiltration (CUF) during extracorporeal membrane oxygenation (ECMO) because of severe diuretic-resistant hypervolemia. Their mean age was 9.8 +/- 1.5 days, their mean body weight 3.0 +/- 0.1 kg. The membrane surface area of the hemofilters ranged from 0.015 m2 to 0.2 m2 and the priming volume from 3.7 to 15 ml. For pump-driven hemofiltration a roller pump with pressure alarms, an air trap, an air bubble detector, and small blood lines was used. Fluid balance was controlled by a microprocessor controlled unit. The ultrafiltrate substitution fluid was based on bicarbonate in the majority of the patients and was partially or totally replaced according to the clinical situation. The mean duration of renal support was 97 +/- 20 hours, ranging from 14 to 720 hours. During arterio-venous and veno-venous hemofiltration the mean blood flow rates were 7.0 +/- 1.2 ml/min and 23.1 +/- 2.4 ml/min (P < 0.01), respectively, and the mean ultrafiltration rates 3.3 +/- 0.4 and 9.5 +/- 1.9 ml/min/m2 (P < 0.01), respectively. During continuous hemodiafiltration urea clearances increased by 300%. Overall survival rate was 66%. CRRT related complications included local bleeding at the catheter entrance site, partial thrombosis of the inferior or superior caval veins and transient ischemia due to femoral artery catheters. Continuous hemofiltration either driven in the arterio-venous or veno-venous mode is a very effective method of renal support for critically ill neonates to control fluid balance and metabolic derangement. Urea clearance can be improved by adding some dialysate fluid in a countercurrent direction to blood flow.
authors.affiliation: Department of Pediatrics, University of Graz, Austria. gerfried.zobel@kfunigraz.ac.at
authors.forename: G
authors.initials: G
authors.lastname: Zobel
authors.forename: S
authors.initials: S
authors.lastname: Rödl
authors.forename: B
authors.initials: B
authors.lastname: Urlesberger
authors.forename: M
authors.initials: M
authors.lastname: Kuttnig-Haim
authors.forename: E
authors.initials: E
authors.lastname: Ring
mesh_terms: D058186:Acute Kidney Injury / Q000628:therapy*; D003422:Critical Care; D016638:Critical Illness; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D017583:Hemodiafiltration / Q000379:methods; D006440:Hemofiltration / Q000379:methods; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D017582:Renal Replacement Therapy / Q000379:methods*